Aflac Incorporated (NYSE:AFL) Shares Bought by Barclays PLC

Barclays PLC raised its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 2.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,427,628 shares of the financial services provider's stock after purchasing an additional 36,501 shares during the quarter. Barclays PLC owned 0.26% of Aflac worth $147,673,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in AFL. SageView Advisory Group LLC raised its position in shares of Aflac by 9.1% during the 4th quarter. SageView Advisory Group LLC now owns 2,058 shares of the financial services provider's stock valued at $213,000 after buying an additional 171 shares in the last quarter. Savvy Advisors Inc. increased its stake in Aflac by 4.4% during the fourth quarter. Savvy Advisors Inc. now owns 3,230 shares of the financial services provider's stock worth $334,000 after acquiring an additional 136 shares during the last quarter. Advisors Capital Management LLC raised its position in Aflac by 6.9% during the fourth quarter. Advisors Capital Management LLC now owns 11,030 shares of the financial services provider's stock valued at $1,141,000 after purchasing an additional 711 shares during the period. Sagespring Wealth Partners LLC bought a new stake in shares of Aflac in the 4th quarter valued at approximately $647,000. Finally, Nicolet Bankshares Inc. increased its position in shares of Aflac by 5.6% during the 4th quarter. Nicolet Bankshares Inc. now owns 3,754 shares of the financial services provider's stock valued at $388,000 after purchasing an additional 199 shares during the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Aflac

In other Aflac news, Director Charles D. Lake II sold 29,802 shares of the firm's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the transaction, the director now owns 49,962 shares of the company's stock, valued at approximately $5,360,422.98. This trade represents a 37.36 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the sale, the director now directly owns 25,393 shares in the company, valued at $2,733,048.59. This trade represents a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.90% of the company's stock.

Aflac Stock Up 0.0 %

Shares of NYSE AFL traded up $0.01 during mid-day trading on Friday, reaching $107.35. 2,294,639 shares of the company were exchanged, compared to its average volume of 2,125,455. The firm has a 50-day moving average of $106.72 and a 200 day moving average of $107.24. Aflac Incorporated has a 1 year low of $80.59 and a 1 year high of $115.50. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The stock has a market cap of $58.59 billion, a price-to-earnings ratio of 11.18, a P/E/G ratio of 3.24 and a beta of 0.81.

Aflac (NYSE:AFL - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, research analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on AFL. Morgan Stanley lowered their price target on Aflac from $105.00 to $100.00 and set an "equal weight" rating for the company in a research report on Thursday, April 10th. Barclays reduced their price objective on shares of Aflac from $98.00 to $95.00 and set an "underweight" rating on the stock in a research report on Friday, February 7th. StockNews.com upgraded Aflac from a "sell" rating to a "hold" rating in a report on Friday, February 14th. Piper Sandler boosted their price objective on Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a report on Wednesday, April 2nd. Finally, Wells Fargo & Company decreased their target price on Aflac from $104.00 to $102.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 19th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Aflac presently has a consensus rating of "Hold" and an average price target of $103.93.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.